Uniting forces in physics and medicine
Following the very successful ‘Physics for Health’ workshop held at CERN on 2-4 February this year, a strategy document has recently been issued. It outlines the main issues discussed at the workshop and indicates the most promising avenues in the field of medical applications derived from physics.

Rolf Heuer, CERN Director General talks to the participants in the “Physics for Health in Europe” workshop.
“Physics for Health in Europe” workshop at CERN.
Although physics research is at the origin of an increasing number of medical techniques used for the early diagnosis and treatment of tumors and other diseases, the workshop was a novel initiative to bring medical doctors and physicists together to discuss global strategies. “CERN was a natural host for such a workshop”, says Manjit Dosanjh. “It is a neutral ground scientifically and most European countries have access and participate in CERN activities”. “CERN has a long tradition in developing instruments for use in medicine”, adds Ugo Amaldi, member of the scientific programme committee. “It’s here that David Townsend and Alan Jeavons took the first PET image in 1977. Also, making use of the CERN facilities and beams we have developed the accelerating modules, which are the heart of CNAO, the hadron therapy centre recently inaugurated in Italy, and MEDAustron, a similar centre currently under construction in Austria”.
A guided tour of CNAO, the recently inaugurated hadron therapy centre in Italy.
One of the most important conclusions of the workshop was the proposal that CERN should launch and coordinate the activities of an international collaboration centred on a new low-cost facility for hadron therapy using the most advanced technologies (such as superconductivity), with the aim of participating not only in the design but also in construction. “This new study of an accelerator for cancer therapy will be similar to the Proton-Ion Medical Machine Study (PIMMS) started in 1996”, explains Ugo Amaldi. The strategy document also highlights the importance of building a consortium of European research facilities that could supply innovative radioisotopes to groups which develop radiopharmaceuticals for diagnostics and therapy. Several facilities could participate in such a consortium; certainly CERN’s ISOLDE is one.
A short video tour of the recently inaugurated hadron therapy centre in Heidelberg (Germany).
The second Physics for Health in Europe workshop (PHEE12) will be held in 2012.